Expertise in
15
conditions

Qiang G. Sun

Peking Union Medical College Hospital, Peking Union Medical College, 
Beijing, CN 
Expertise in
15
conditions
Peking Union Medical College Hospital, Peking Union Medical College, 
Beijing, CN 

Overview

Qiang Sun practices practicing medicine in Beijing, China.

Sun is highly rated in 15 conditions, according to our data. Their clinical expertise encompasses Breast Cancer, ECHO Virus, Triple-Negative Breast Cancer, Mastectomy, and Liver Transplant.

They are actively involved in clinical research, co-authoring 967 peer reviewed articles and participating in 2 clinical trials.

Locations

Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
Other Locations
Yanta Road 58, Xi'an, 710054, China
1037 Luoyu Road, Wuhan, 430074, China
No. N1, Shangcheng Avenue, Yiwu, 322000, China
66 Bisheng Road, Chengdu, China
No. 41, Longtou Road, Zaozhuang, 277100, China
20 Dongda Street, Beijing, 100071, China
44 Wenhuaxi Rd, Jinan, 250012, China
20 Dongdajie Road, Beijing, 100071, China
No 155 Nanjing North Street, Shenyang, 110002, China
91 Qianjin West Road, Kunshan, 215300, China
20 Dongda Street, P.R, Beijing, 100071, China
No. 48, Zhonghua Road, Fuxin, 123000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Phase III Study Comparing TAC (Docetaxel, Doxorubicin, Cyclophosphamide) With TCX ( Docetaxel, Cyclophosphamide, Capecitabine) as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
A Randomized, Phase III Study Comparing TAC (Docetaxel, Doxorubicin, Cyclophosphamide) With TCX ( Docetaxel, Cyclophosphamide, Capecitabine) as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
Enrollment Status: Completed
Publish Date: June 15, 2025
Intervention Type: Drug
Study Drugs: Docetaxel, Doxorubicin, Cyclophosphamide, Capecitabine
Study Phase: Phase 3
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
Enrollment Status: Unknown
Publish Date: April 19, 2017
Intervention Type: Drug
Study Drugs: 5-Fu/Epirubicin/CTX Following Docetaxel, Docetaxel/Capecitabine Followed by Capecitabine/Epirubicin/Cyclophosphamide
Study Phase: Phase 3
View 1 Less Clinical Trial

967 Total Publications

Comment on: comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
Comment on: comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2026

Frequently Asked Questions about Qiang G. Sun

Is Qiang G. Sun a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Qiang G. Sun is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Qiang G. Sun participate in research or clinical trials?

Yes. Qiang G. Sun has published 967 articles and abstracts on conditions like Breast Cancer. You can view a list of Qiang G. Sun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sun's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 97 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile